Table 5 SF-36 component scores throughout the study (mean ± sd) (ES: effect sizes)
baseline | week 12 | week 24 | P | |
|---|---|---|---|---|
PF (physical function) | 27.2 ± 18.4 | 29.2 ± 16.5 | 36.0 ± 21.4** | = 0.0079 |
ES | -0.11 | -0.48 | ||
RP (role physical) | 2.56 ± 12.6 | 8.33 ± 25.2 | 11.54 ± 28.0* | = 0.0657 |
ES | -0.46 | -0.71 | ||
BP (bodily pain) | 10.9 ± 14.4 | 18.2 ± 17.9* | 24.2 ± 20.6*** | <0.0001 |
ES | -0.51 | -0.92 | ||
GH (global health) | 26.3 ± 17.9 | 28.4 ± 18.5 | 29.6 ± 17.4 | = 0.4321 |
ES | -0.12 | -0.18 | ||
VT (vitality) | 13.6 ± 13.4 | 18.7 ± 19.4 | 19.9 ± 18.6* | = 0.0301 |
ES | -0.38 | -0.47 | ||
SF (social function) | 35.6 ± 27.4 | 41.0 ± 28.5 | 42.2 ± 29.9 | = 0.2150 |
ES | -0.20 | -0.26 | ||
RE (role emotional) | 19.7 ± 32.2 | 24.8 ± 38.8 | 29.1 ± 39.9 | = 0.3293 |
ES | -0.16 | -0.29 | ||
MH (mental health) | 31.5 ± 21.5 | 38.1 ± 21.3 | 42.8 ± 24.6** | = 0.0023 |
ES | -0.31 | -0.53 |